In 2008, cancer accounted for more than 7.6 million deaths worldwide. By 2030, that number is projected to more than double, with 70% of deaths occurring in lower and middle income countries.
Radiation therapy is recognized as an essential tool in the cure and palliation of cancer, and is indicated in over half of new cancer patients. In LMICs, the need for radiation therapy may in fact be higher due to more advanced stage of disease at presentation.
The Board of the UICC has approved the convening of a Global Task Force on Radiotherapy for Cancer Control (GTFRCC) to address this very challenge under their purpose – “…to unite the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda.”